Afficher la couverture 'Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis | Burgel, Pierre-Régis' en grand format
/5

0 avis

Real-Life Safety and Effectiveness of Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis

Archive ouverte

Burgel, Pierre-Régis | Munck, Anne | Durieu, Isabelle | Chiron, Raphaël | Mely, Laurent | Prevotat, Anne | Murris-Espin, Marlene | Porzio, Michele | Abely, Michel | Reix, Philippe | Marguet, Christophe | Macey, Julie | Sermet-Gaudelus, Isabelle | Corvol, Harriet | Bui, Stéphanie | Lemonnier, Lydie | Dehillotte, Clémence | da Silva, Jennifer | Paillasseur, Jean-Louis | Hubert, Dominique | Mounard, Julie | Poulet, Claire | Rames, Cinthia | Person, Christine | Troussier, Françoise | Urban, Thierry | Dalphin, Marie-Laure | Dalphin, Jean-Claude | Pernet, Didier | Richaud-Thiriez, Bénédicte | Fayon, Mickael | Macey-Caro, Julie | Campbell, Karine | Laurans, Muriel | Borderon, Corinne | Heraud, Marie-Christine | Labbé, André | Montcouquiol, Sylvie | Bassinet, Laurence | Remus, Natascha | Fanton, Annlyse | Houzel-Charavel, Anne | Huet, Frédéric | Perez-Martin, Stéphanie | Boldron-Ghaddar, Amale | Scalbert, Manuela | Camara, Boubou | Llerena, Catherine | Pin, Isabelle | Quétant, Sébastien | Cottereau, Aurélie | Deschildre, Antoine | Gicquello, Alice | Perez, Thierry | Stervinou-Wemeau, Lidwine | Thumerelle, Caroline | Wallaert, Benoit | Wizla, Nathalie | Languepin, Jane | Ménétrey, Céline | Dupuy-Grasset, Magalie | Bazus, Lucie | Buchs, Clelia | Jubin, Virginie | Werck-Gallois, Marie-Christine | Mainguy, Catherine | Perrin, Thomas | Toutain-Rigolet, Agnès | Durupt, Stéphane | Reynaud, Quitterie | Nove-Josserand, Raphaele | Baravalle-Einaudi, Melisande | Coltey, Bérangère | Dufeu, Nadine | Dubus, Jean-Christophe | Stremler, Nathalie | Caimmi, Davide | Billon, Yves | Derelle, Jocelyne | Kieffer, Sébastien | Pichon, Anne-Sophie | Schweitzer, Cyril | Tatopoulos, Aurélie | Abbes, Sarah | Bihouée, Tiphaine | Danner-Boucher, Isabelle | David, Valérie | Haloun, Alain | Tissot, Adrien | Leroy, Sylvie | Bailly-Piccini, Carole | Clément, Annick | Tamalet, Aline | Honoré, Isabelle | Kanaan, Reem | Martin, Clémence | Bailly, Cécile | Chédevergne, Frédérique | de Blic, Jacques | Fauroux, Brigitte | Le Bourgeois, Murielle | Delaisi, Bertrand | Gérardin, Michèle | Abély, Michel | Ravoninjatovo, Bruno | Belleguic, Chantal | Desrues, Benoit | Brinchault, Graziella | Dagorne, Michel | Deneuville, Eric | Lefeuvre, Sylvaine | Dirou, Anne | Le Bihan, Jean | Ramel, Sophie | Dominique, Stéphane | Payet, Annabelle | Kessler, Romain | Rosner, Vincent | Weiss, Laurence | de Miranda, Sandra | Grenet, Dominique | Hamid, Abdoul | Picard, Clément | Brémont, François | Didier, Alain | Labouret, Géraldine | Mittaine, Marie | Murris-Espin, Marlène | Têtu, Laurent | Cosson, Laure | Giraut, Charlotte | Henriet, Anne-Cécile | Mankikian, Julie | Marchand, Sophie | Hugé, Sandrine | Storni, Véronique | Coirier-Duet, Emmanuelle

Edité par CCSD ; American Thoracic Society -

International audience

Consulter en ligne

Suggestions

Du même auteur

The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study

Archive ouverte | Burgel, Pierre-Régis | CCSD

International audience

The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study

Archive ouverte | Burgel, Pierre-Régis | CCSD

International audience. Background Elexacaftor-tezacaftor-ivacaftor has been approved in Europe for people with cystic fibrosis with at least one F508del CFTR variant. Additionally, it is approved by the US Food and...

Multisystemic Effects of Elexacaftor–Tezacaftor–Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease

Archive ouverte | Burgel, Pierre-Régis | CCSD

International audience. ationale: Limited data exist on the safety and effectiveness of elexacaftor-tezacaftor-ivacaftor (ETI) in people with cystic fibrosis (pwCF) and advanced lung disease. Objectives: To evaluate...

Chargement des enrichissements...